Journal of Clinical & Experimental Dermatology Research
Open Access

Prashant Kale

Publications

• Research Article
  A New Topical Formulation of Minoxidil and Finasteride Improves Hair Growth in Men with Androgenetic Alopecia
  Author(s): Saifuddin Sheikh, Ateeq Ahmad, Shoukath M Ali, Moghis U Ahmad, Mahesh Paithankar, Dipak Saptarshi, Prashant Kale, Kirti Maheshwari, Hemant V Barkate, Pathak HL, Mohammad Mushtaq and Imran Ahmad Saifuddin Sheikh, Ateeq Ahmad, Shoukath M Ali, Moghis U Ahmad, Mahesh Paithankar, Dipak Saptarshi, Prashant Kale, Kirti Maheshwari, Hemant V Barkate, Pathak HL, Mohammad Mushtaq and Imran Ahmad
  
  Objectives: To compare the safety and efficacy of MorrF (combination of Minoxidil [5%]+Finasteride [0.1%] lipid solution) with Minoxidil (5%) solution in adult male patients suffering from Androgenetic Alopecia (AGA). Background: AGA is one of the three most common forms of non-scarring alopecia with approximately 95% of hair loss cases in men and women. Fifty percent of men by age 50 years exhibit some degree of AGA. Currently there are two effective treatments available for the treatment of AGA in men: topical Minoxidil and oral Finasteride. Clinical studies have demonstrated that both Minoxidil and Finasteride have well established therapeutic effect in the management of AGA. Materials and methods: Safety study in rats was carried out for 28 days with topical application of MorrF twice a day for 28 days. Human Pharmac.. View More»
  DOI: 10.4172/2155-9554.1000253

  Abstract PDF

Relevant Topics